| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gepsman Martin J serves as a Director at CME. Across recent SEC filings that breaks down to 0 buys and 26 sells. Those positions are worth an estimated $6.5M at current prices.
Historically, Gepsman Martin J's trades have earned a middling insider score of 50/100 across 11 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -2.4%.
The biggest single holding is CME (~$6.5M) as Director. The recent filings there lean toward selling, a net 23,700 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2018 | CME Cme Group Inc. | Director | Sell | 300 | $164.29 | $49,287.00 | -0.7% |